Bacteria can utilize alternative σ factors to regulate sets of genes in response to 31 changes in the environment. The largest and most diverse group of alternative σ factors are the 32 Extracytoplasmic Function (ECF) σ factors. σ P is an ECF σ factor found in Bacillus anthracis, B. 33 cereus, and B. thuringiensis. Previous work showed σ P is induced by ampicillin, a β-lactam 34 antibiotic, and required for resistance to ampicillin. However, it was not known how activation of 35 σ P is controlled or what other antibiotics may activate σ P . Here we report that activation of σ P is 36 specific to a subset of β-lactams and σ P is required for resistance to these β-lactams. We 37 demonstrate that activation of σ P is controlled by the proteolytic destruction of the anti-σ factor, 38
example, the E. coli anti-σ factor, RseA, is degraded in response to outer membrane stress 81 leading to σ E activation (16, 17) . DegS, a serine protease, cleaves the anti-σ factor RseA at site-82 1 (14, 18, 19) . After site-1 cleavage, the conserved site-2 protease, RseP, cleaves RseA within 83 the membrane leading to increased σ E activity (14, 20, 21) . Similarly, the σ W anti-σ factor, RsiW, 84 from B. subtilis is proteolytically degraded by site-1 and site-2 proteases. In the case of RsiW, 85 the site-1 protease is PrsW, a metalloprotease unrelated to DegS. PrsW cleaves RsiW in 86 response to antimicrobial peptides, vancomycin and pH change (22) (23) (24) . RsiW is further 87 processed by the conserved site-2 protease RasP, a homolog of RseP (15) . 88
The closely related ECF30 family member, σ V from B. subtilis, is activated by lysozyme 89 (25-29). Activation of σ V differs from σ E and σ W activation in that σ V is not controlled by a 90 dedicated site-1 protease but instead utilizes signal peptidases (30, 31) . Signal peptidases are 91 essential proteases which are required to cleave substrates secreted from the general secretion 92 or twin arginine secretion systems (32-34). The anti-σ factor, RsiV binds to lysozyme which 93 allows signal peptidase to cleave RsiV at site-1 (30, 31). This allows the site-2 protease, RasP, 94 to cleave RsiV, leading to σ V activation (35) . 95
Previous studies found σ P is induced by ampicillin and its activity is required for 96 resistance to ampicillin (5). The activity of σ P is inhibited by the transmembrane anti-σ factor, 97
RsiP (5, 6). However, whether σ P is activated specifically by ampicillin or more generally by cell 98 wall stress is not known. In B. subtilis, activation of σ V is specific to lysozyme (26, 27), while 99 activation of σ W , σ X and σ M is in response to more general cell envelope stress (9, 36, 37) . Here, 100
we show σ P is activated by a specific subset of β-lactams and this activation occurs via 101 regulated intramembrane proteolysis of the anti-σ factor, RsiP. 102 103 later. In contrast, neither cefoperazone nor cefsulodin were able to induce on the plates or in 130 liquid ( Fig. 1 and 2B ). This confirms our observation that a sub-set of β-lactams induce σ P 131 activation. 132
We found that deletion of the sigPrsiP genes blocked expression of P sigP -lacZ in the 133 presence of β-lactams ( Fig. 1 and Fig. 2C ) demonstrating σ P is required for induction of P sigP -134 lacZ in response to β-lactams. When we introduced a low copy plasmid containing P sigP -135 sigP + rsiP + into the ΔsigPrsiP mutant (ΔsigPrsiP/pSigPRsiP), we restored the induction of P sigP -136 lacZ in response to cefoxitin (Fig. 2C ). Taken together, these data suggest a subset of β-lactam 137 antibiotics activate σ P . 138 139 σ P and Bla1 are involved in resistance to some β-lactams. 140
To determine the impact of σ P on resistance to β-lactams, we measured the minimal 141 inhibitory concentration (MIC) of wild type and a ΔsigPrsiP mutant for several β-lactams. We 142 found the wild type was greater than 100-fold more resistant to ampicillin, methicillin, and 143 cephalothin than was the ΔsigPrsiP mutant (Table 1) . Wild type was 16 to 50-fold more resistant 144 to cefmetazole, cefoxitin and cephalexin than the mutant (Table 1 ). There was little or no 145 difference in resistance to piperacillin, cefoperazone and cefsulodin which also failed to activate 146 σ P (Table 1 and Fig. 1 ). We also demonstrate that complementing the ΔsigPrsiP mutant with a 147 plasmid carrying P sigP -sigP + -rsiP + restored resistance to ampicillin and cefoxitin (Table 2 ). For 148 reasons that remain unclear, strains containing plasmids including empty vector have slight 149 increases in β-lactam resistance. However, this does not impact the observation that the 150 presence of P sigP -sigP + -rsiP + restored resistance to ampicillin and cefoxitin. 151
Since σ P was shown to control expression of hd73_3490 (referred to hereafter as bla1), 152 which encodes a β-lactamase, we sought to determine if this gene played a role in resistance to 153 β-lactams. We made a deletion of bla1 and determined the MIC of ampicillin and cefoxitin for 154 this strain. The bla1 mutant was 8 to 16-fold more sensitive to ampicillin, ~5 fold more sensitive to methicillin but no more sensitive to cefoxitin than wild type (Table 2) . This contrasts with the 156 sigP mutant which is greater than 1000-fold more sensitive to ampicillin, 600-fold more sensitive 157 to methicillin and ~25-fold more sensitive to cefoxitin than the wild type (Table 2 ). This suggests 158 that Bla1 plays a more important role in resistance to ampicillin and methicillin than to cefoxitin. 159 Furthermore, our data suggests that while Bla1 contributes to β-lactam resistance, additional σ P 160 regulated genes must also contribute to β-lactam resistance. 161
When we tested various β-lactams for induction of P sigP -lacZ on X-gal plates, we did not 162 consistently observe a strong zone of induction surrounding ampicillin and methicillin ( Fig. 1) . 163
We hypothesized this weak induction zone was because the wild type efficiently produced β-164 lactamases which degraded the inducer (ampicillin and methicillin). Thus, we were unable to 165 observe the increased production of β-galactosidase. To test this hypothesis, we determined the 166 effect of a Δbla1 mutant on σ P activation. We found that in the Δbla1 mutant, ampicillin and 167 methicillin produced more distinct zones of induction ( Fig. 1 ). However, all other induction zones 168 of the Δbla1 mutant were similar to wild type. Thus, in the absence of Bla1 which degrades 169 ampicillin and methicillin, we detected greater induction of P sigP -lacZ expression. Taken 170 together, these observations suggest that the weak ampicillin induction of P sigP -lacZ on plates is 171 in part due to the efficient degradation of the inducer by β-lactamases. 172
173
RsiP is degraded in response to cefoxitin in a dose-dependent manner. 174
The anti-σ factors of other ECF01 family members are degraded which leads to the 175 activation of their cognate σ factors (7, 14, 15) . We sought to determine if β-lactams activate σ P 176 by inducing degradation of RsiP. To investigate this, we constructed a strain with an 177 anhydrotetracycline-inducible copy of green fluorescent protein (GFP) fused to the N-terminus 178 of RsiP (GFP-RsiP). The inducible promoter allows us to uncouple expression of RsiP from 179 induction of σ P . The GFP-RsiP fusion allows us to follow the fate of the cytoplasmic portion of 180 membrane ( Fig. S2 ). We then induced the synthesis of GFP-RsiP in exponential phase cells 182 and monitored its processing before and after treatment with cefoxitin. We chose to utilize 183 cefoxitin for these experiments because cefoxitin induces σ P activation over a wide 184 concentration range and the ΔsigPrsiP mutant strain grows at most of these concentrations (Fig. 185 2A and Table 1 ). Cell pellets were then lysed by sonication and western blots were performed 186 using anti-RsiP antisera against the extracellular portion of RsiP or anti-GFP antisera which 187 detects GFP fused to the intracellular portion of RsiP. highly-conserved site-2 protease, RseP and RasP, respectively (14, 15). We hypothesize that 206 activation of σ P requires multiple proteases including the conserved site-2 protease RasP to degrade RsiP. To test this we used BLAST to identify a putative membrane embedded 208 metalloprotease, HD73_4103, which is 76% similar and 60% identical to B. subtilis RasP and is 209 hereafter referred to as RasP ( Fig. S5 ) (38-43). To determine if RasP was required for σ P 210 activation, we generated a strain containing a deletion of rasP and the P sigP -lacZ reporter. In the 211 absence of RasP, we do not detect increased expression of P sigP -lacZ reporter in response to 212 cefoxitin ( Fig. 2C ). In MIC experiments, we found that, similar to the ΔsigPrsiP mutant, the 213
ΔrasP mutant was more sensitive to ampicillin and cefoxitin ( Table 2 ). We found both resistance 214 to β-lactams and induction of P sigP -lacZ could be complemented when a plasmid expressing 215 rasP + was introduced into the ΔrasP mutant ( Fig. 2C and Table 2 ). These data suggest RasP is 216 required for σ P activation. 217 218
RasP is required for degradation of RsiP. 219
To determine if RasP is required for degradation of RsiP, we expressed the GFP-RsiP 220 fusion in both wild type and a ∆rasP mutant. We treated cells with 5 µg/mL cefoxitin for various 221 To further characterize the σ P signal transduction system, we isolated mutants which 230 resulted in constitutive expression of P sigP -lacZ. We selected for mutants with increased 231 resistance to cefoxitin by plating cultures of the wild type P sigP -lacZ strain (THE2549) on LB 232 cefoxitin 200 µg/ml agar. At this concentration of cefoxitin, wild type B. thuringiensis fails to grow. These strains were tested for P sigP -lacZ expression in the absence of cefoxitin by 234 streaking on LB X-gal. We isolated 8 independent mutants with increased resistance to cefoxitin 235 that have constitutive P sigP -lacZ expression. We hypothesized these strains harbored mutations 236 in rsiP. We PCR amplified and sequenced the sigP and rsiP genes from the constitutive 237 mutants. The 8 constitutive mutants contained mutations in different regions of the rsiP gene 238 that resulted in C-terminal truncations of RsiP ( Fig. S7 ). We selected four rsiP mutants for 239 further study. We found that each mutant strain showed increased P sigP -lacZ expression even in 240 the absence of β-lactams ( Fig. 5 ). When a wild type copy of rsiP (pSigPRsiP) was introduced to 241 each of these mutants, P sigP -lacZ expression was no longer constitutive but was induced in the 242 presence of cefoxitin ( Fig. S8 ). This indicates that the rsiP mutations were responsible for the 243 increased P sigP -lacZ expression. 244
In the σ V and σ W systems, RasP cleaves the anti-σ factors RsiW and RsiV within the 245 transmembrane domain to activate the cognate σ factors (15, 35). The RsiP transmembrane is 246 predicted to be residues 54-71 based on TMHMM (44). Two of the four RsiP truncations 247 produce proteins with the transmembrane domain intact while the remaining RsiP truncations 248 lack the transmembrane domain. Since RasP is known to cleave proteins within the 249 transmembrane domain we hypothesized that those truncations which still contain a 250 transmembrane domain would require RasP in order to activate σ P . To test this, we introduced 251
the ΔrasP mutation into each of the rsiP mutants. In the absence of RasP, strains containing 252 truncations which have a transmembrane domain (RsiP 1-220 , RsiP 1-80 ; Fig. 4 and Fig. S7 ) no 253 longer constitutively activate σ P (Fig. 5 ). However, the strains with the rsiP truncation lacking the 254 transmembrane domain (RsiP 1-16 , RsiP 1-61 ) constitutively activate σ P even in the absence of 255
RasP (RsiP 1-16 , RsiP 1-61 ; Fig. 4 and S5). Thus, RasP is required for σ P activation when the 256 transmembrane domain of RsiP is intact, consistent with the role of RasP as a site-2 protease. 257 258
RasP cleaves within the transmembrane domain of RsiP and is not the regulated step in 259 σ P activation. 260
In the case of σ W and σ V the rate-limiting step in σ factor activation is site-1 cleavage 261 (15, 35). Since the identity of the site-1 protease is not currently known we sought to determine 262
if RasP cleavage of RsiP is a rate-limiting step in σ P activation. To test this, we constructed 263 truncations of GFP-RsiP that lack the extracellular portion of RsiP. One truncation includes the 264 transmembrane domain (gfp-rsiP 1-72 ) and one truncation lacks the transmembrane domain (gfp-265 rsiP 1-53 ). We expressed the truncated GFP-RsiP proteins in wild type and ∆rasP backgrounds 266 and exposed these strains to cefoxitin (5 µg/ml). In wild type strains we found both GFP-RsiP 1-72 267 and GFP-RsiP 1-53 were degraded ( the novel ECF σ factor, σ P , is induced in the presence of ampicillin and initiates transcription of 289 β-lactamases (5). Here we demonstrated σ P responds specifically to a subset of β-lactams, 290 while other β-lactams and cell wall targeting antibiotics fail to induce σ P activation. We also 291 showed σ P confers varying degrees of resistance to these β-lactam antibiotics. We found that 292 σ P was not required for resistance to other cell wall antibiotics including vancomycin, nisin, 293 bacitracin suggesting specificity in resistance to β-lactams and not a general cell envelope 294 stress response. 295
For ECF σ factors to be activated, their cognate anti-σ factors must be inactivated. This proteases to cleave the anti-σ factor at site-1 (14, 22, 30, 47, 48) while site-2 cleavage is carried 302 out by the conserved site-2 protease (14, 15, 35). We hypothesize that σ P is activated in a 303 similar manner. Our data indicate σ P is released from RsiP by proteolytic degradation when β-304 lactams are present. We found RasP is required for activation of σ P . We also observe that a 305
RsiP degradation product approximately the size of our predicted RasP substrate accumulates 306 in a ∆rasP mutant. This indicates RasP is required for degradation of RsiP. Our data also 307 suggest, similar to other anti-σ factors, site-2 cleavage of RsiP is not the rate-limiting step since 308 the C-terminal RsiP truncations are constitutively degraded and lead to constitutive σ P activation 309 in the absence of β-lactams. Thus, we hypothesize that RasP is required for site-2 cleavage of RsiP and an as yet unidentified protease is required to initiate degradation of RsiP by cleaving 311
RsiP at site-1. We hypothesize, that like other ECF σ factors activated by regulated 312 intramembrane proteolysis, site-1 cleavage of RsiP is likely the rate-limiting step in σ P activation. 313
Our data suggest a subset of β-lactams induce σ P activation. We found, in addition to 314 ampicillin, σ P is activated by cefoxitin, cefmetazole, cephalothin, cephalexin, and methicillin; but 315 not by piperacillin, cefoperazone, cefsulodin, or antibiotics that target other steps in 316 peptidoglycan biosynthesis. This raises the question: what is the signal for σ P activation? The β-317 lactams could be sensed directly or indirectly. For example RsiV directly senses lysozyme and 318 degradation of RsiV is rapid (31). In contrast activation of σ E is indirect and due to buildup of 319 products that occur when the outer membrane is damaged (31, 49). Our data suggest RsiP 320 degradation is a relatively slow process. One possible interpretation of this is that β-lactam 321 induced PG damage must accumulate to induce RsiP degradation. We hypothesize that the β-322 lactams we tested have different affinities for PBPs and this affinity may explain why some β-323 lactams induce σ P while others do not.
In other organisms, including Streptococcus 324 pneumoniae, B. subtilis and E. coli, β-lactams can differentially target PBPs (50-52). This raises 325 the possibility that activation of σ P could be the result of inhibition of specific PBPs. 326
Unfortunately, at this time we do not know which PBPs are targeted by the different β-lactams in 327 B. thuringiensis. Thus, the precise mechanism and signal responsible for σ P activation remain to 328 be clearly defined. 329 330
Materials and Methods 331

Media and Growth Conditions 332
All B. thuringiensis strains are isogenic derivatives of AW43, a derivative of B. 333 thuringiensis subspecies kurstaki strain HD73 (53). All strains and genotypes can be found in 334 Table 3 . All B. thuringiensis strains were grown in or on LB media at 30 o C unless otherwise 335 specified. Cultures of B. thuringiensis were grown with agitation in a roller drum. Strains 336 containing episomal plasmids were grown in LB containing chloramphenicol (cam, 10 µg/ml) or 337 erythromycin (erm, 10 µg/ml). E. coli strains were grown at 37 o C using LB-ampicillin (amp, 100 338 µg/ml) or LB-cam (10 µg/ml) media. To screen for threonine auxotrophy, B. thuringiensis strains 339
were patched on minimal media plates without or with threonine (50 µg/ml) (54, 55). The β- To construct deletion mutants, we cloned 1 kb DNA upstream and 1 kb downstream of 353 the site of desired deletion using primers listed in Table S1 onto Plasmids were introduced into B. thuringiensis by electroporation (59, 60). Briefly, 376 recipient cells were grown to late-log phase at 37 o C. For each transformation, cells (1.5 ml) 377 were pelleted by centrifugation (9,000 x g) and washed twice in room temparature sterile water. 378
After careful removal of all residual water, 100 µl of sterile 40% PEG 6000 (Sigma) was used to 379 gently resuspend cells. Approximately 2-10 µl of unmethylated DNA (>50 ng/µl) was added to 380 cells and transferred to a 0.4 cm gap electroporation cuvette (Bio-Rad). Cells were exposed to 381 2.5kV for 4-6 msec. LB was immediately added and cells were incubated at 30 o C for 1-2 hours 382 prior to plating on selective media. 383 384
Construction of deletions or promoter-lacZ fusions in B. thuringiensis 385
To generate unmarked mutants and thrC::P sigP -lacZ strains, we used plasmid vectors 386 containing the temperature-sensitive origin of replication (pE194 ori) from the pMAD plasmid 387 (57). At permissive temperatures (30 o C), pMAD replicates episomally as a plasmid. At non-388 permissive temperatures (42 o C) pMAD must integrate into the chromosome via homologous 389 recombination otherwise the plasmid will be lost to segregation and the strain will become 390 sensitive to erythromycin. Plasmids were transformed into a B. thuringiensis recipient strain and 391 selected for on LB-erm agar at 30 o C. To select for the integration of the deletion plasmid into the 392 recipient strain genome, plasmid-containing bacteria were grown at 42 o C on LB-erm plates. The 393 plasmid-integrated strain was then struck on LB agar at 30 o C twice. Individual colonies were 394 patched on LB and LB-erm agar to identify the erm-sensitive bacteria which had lost the 395 deletion plasmid by segregation. To verify each deletion, genomic DNA was isolated from each 396 strain candidate and PCR was used to verify the deletion. Integration of P sigP -lacZ fusion into the 397 thrC operon results in threonine auxotrophy and can be identified by lack of growth on minimal 398 media plates without threonine. 399 400
Zones of Inhibition and Zones of Induction 401
To determine the zones of inhibition and induction by various antibiotics, we first washed 402 mid-logarithmically grown cells in fresh LB. Washed cells were diluted 1:100 in molten LB agar 403 containing X-gal (100 µg/ml) and poured into empty 100 mm Petri dishes. Sterile cellulose disks 404 (8 mm) were saturated with different antibiotics and allowed to dry for greater than 10 minutes. 405
After each antibiotic disk was placed on the solidified agar, plates were incubated at 30 o C 406 overnight before observing. 407 408
β-Galactosidase Assays 409
To quantify expression from the sigP promoter, we measured the β-galactosidase 410 activity of cells containing a P sigP -lacZ promoter fusion. Overnight cultures were diluted 1:50 in fresh LB media and incubated for 3 hours at 30 o C. One ml of each subculture was pelleted 412 (9,000 x g), washed (in LB broth) and resuspended in 1 ml LB broth lacking or including 413 specified antibiotics. After 1 hour of incubation at 37 o C, 1 ml of each sample was pelleted and 414 resuspended in 200 µl of Z-buffer. Cells were permeabilized by mixing with 16 µl chloroform and 415 16 µl 2% sarkosyl (26, 61). Permeabilized cells (100 µl) were mixed with 10 mg/ml ortho-416
Nitrophenyl-β-Galactoside (ONPG, RPI, 50 µl) and OD 405 was measured over time using an 417 Infinite M200 Pro plate reader (Tecan). β-Galactosidase activity units (µmol of ONP formed 418 min −1 ) X 10 3 /(OD 600 X ml of cell suspension) were calculated as previously described (62). 419
Experiments were performed in triplicate with the mean and standard deviation shown. 420 421
Minimum Inhibitory Concentration Assay 422
To determine the minimum inhibitory concentration (MIC) for various antibiotics, we 423 Each experiment was performed in triplicate and allowed to incubate for 24 hours at 37 o C before 426 observing growth or no growth. 427 428
Immunoblot Analysis 429
Samples were electrophoresed on a 15% SDS polyacrylamide gel and proteins were 430 then blotted onto a nitrocellulose membrane (GE Healthcare, Amersham). Nitrocellulose was 431 blocked with 5% Bovine Serum Albumin (BSA) and proteins were detected with either 1:10,000 432 anti-GFP or 1:5,000 anti-RsiP 76-275 anti-sera. Streptavidin IR680LT (1:10,000) was used to 433 detect two biotin-containing proteins, PycA (HD73_4231) and AccB (HD73_4487), which serve 434 as loading controls (63, 64). To detect primary antibodies, the blots were incubated with 435 1:10,000 Goat anti-Rabbit IR800CW (Li-Cor) and imaged on an Odyssey CLx Scanner (Li-Cor) 436 or Azure Sapphire (Azure Biosystems). All immunoblots were performed a minimum of three 437 times with a representative example shown. 438 439
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